Metraipolis › archive › dc_fda8b5ddc449

Engineering Immunity: Current Progress and Future Directions of CAR-T Cell Therapy — Europe PMC PMID:41596556

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41596556
DOI
10.3390/ijms27020909
License (as archived)
solo-consultazione
Archived
2026-11-06T17:58:38.080Z
SHA-256 of the archived text
2797cf0521aea1a1b17e25ddca11a3182724fde53f4ff3600bcf4788d1c35bf3
Stable URL of this page
https://metraipolis.com/documento/dc_fda8b5ddc449

How to cite

Engineering Immunity: Current Progress and Future Directions of CAR-T Cell Therapy — Europe PMC PMID:41596556 — Europe PMC (en), https://europepmc.org/article/MED/41596556 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fda8b5ddc449 (Metraipolis archive dc_fda8b5ddc449, sha256 2797cf0521aea1a1b17e25ddca11a3182724fde53f4ff3600bcf4788d1c35bf3)
BibTeX
@misc{dcfda8b5ddc449,
  title = {Engineering Immunity: Current Progress and Future Directions of CAR-T Cell Therapy — Europe PMC PMID:41596556},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41596556},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fda8b5ddc449; sha256 2797cf0521aea1a1b17e25ddca11a3182724fde53f4ff3600bcf4788d1c35bf3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41596556. Agents can read the archived copy with the MCP tool read_document.